glutathione jp monograph Qualitative and quantitative analysis of

61 One of the most well-known studies of TPE, the double-blind placebo-controlled AD management by albumin replacement (AMBAR) trial, hypothesized that withdrawing plasma might flush A plaque from the brain into the plasma where it could be removed, thereby reducing AD signs and symptoms

(2014) characterized the role of senescent cells in tissue biology, demonstrating that senescent cell accumulation is associated with functional changes in aging tissues and providing the rationale for senolytic approaches [2]

There were higher levels in the high-dose group (3035% increase vs 17% increase in the low-dose group)

The concern stems from BPC-157s ability to promote angiogenesis, the formation of new blood vessels